Ozempic in Dubai, a medication primarily prescribed for type 2 diabetes, has recently gained popularity in Dubai as a weight loss solution. This surge is largely driven by social media influencers promoting its use for weight management. However, experts caution against this trend due to potential health risks and the impact on medication availability for diabetic patients.
Understanding Ozempic
Ozempic contains semaglutide, a GLP-1 receptor agonist that helps lower blood sugar levels by stimulating insulin release and reducing glucagon secretion. It also slows stomach emptying, contributing to a feeling of fullness after meals. While weight loss is a common side effect for those with type 2 diabetes, Ozempic is not FDA-approved for weight loss in non-diabetic individuals.
The Trend in Dubai
In Dubai, there's been a notable increase in demand for Ozempic as a weight loss aid. Dr. Aswin Pankajakshan, a specialist endocrinologist at NMC Royal Hospital, noted a significant surge in interest, with many patients inquiring about Ozempic for weight loss purposes. This trend has led to shortages, affecting its availability for those who need it for diabetes management.
Health Risks and Considerations
Using Ozempic without medical supervision can lead to side effects such as nausea, vomiting, diarrhea, and constipation. Additionally, the off-label use of Ozempic for weight loss has contributed to global shortages, making it less accessible for diabetic patients who rely on it for blood sugar control.
Alternative Weight Loss Options
For individuals seeking weight loss solutions, it's advisable to consult healthcare professionals to explore safe and effective options tailored to their needs. Medications like Wegovy, which contains a higher dose of semaglutide and is FDA-approved for weight loss, may be considered under medical guidance.
In summary, while Ozempic has shown potential for weight loss, its use should be carefully managed to avoid health risks and ensure availability for those who need it for diabetes treatment.
